Cargando…

Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center

Tremendous progress has been made in the recognition of primary immune deficiencies (PIDs) in Bulgaria since in 2005 we have joined the J Project Central-Eastern European collaborative program. Ten years later an Expert Centre (ExpC) for Rare Diseases - Primary Immune Deficiencies at the University...

Descripción completa

Detalles Bibliográficos
Autores principales: Naumova, Elissaveta, Lesichkova, Spaska, Milenova, Veneta, Yankova, Petya, Murdjeva, Marianna, Mihailova, Snezhina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535737/
https://www.ncbi.nlm.nih.gov/pubmed/36211402
http://dx.doi.org/10.3389/fimmu.2022.922752
_version_ 1784802839377215488
author Naumova, Elissaveta
Lesichkova, Spaska
Milenova, Veneta
Yankova, Petya
Murdjeva, Marianna
Mihailova, Snezhina
author_facet Naumova, Elissaveta
Lesichkova, Spaska
Milenova, Veneta
Yankova, Petya
Murdjeva, Marianna
Mihailova, Snezhina
author_sort Naumova, Elissaveta
collection PubMed
description Tremendous progress has been made in the recognition of primary immune deficiencies (PIDs) in Bulgaria since in 2005 we have joined the J Project Central-Eastern European collaborative program. Ten years later an Expert Centre (ExpC) for Rare Diseases - Primary Immune Deficiencies at the University Hospital “Alexandrovska”- Sofia was established. In May 2017 The National Register of Patients with Rare Diseases also became operational as a database containing clinical and genetic information for Bulgarian patients with PID. The transfer of data and information on Bulgarian PID patients to the European Primary Immunodeficiency Database, managed by the European Society for Primary Immunodeficiency (ESID) has started in 2020. The total number of registered patients now is 191 (100 men and 91 women), with more than half of them being children (106; 55.5%). Regular updating of the information in the register showed that 5.2% of patients are deceased and the majority (94.8%) is a subject to continuous monitoring as it has been reported for other European countries as well. With the establishment of the ExpC, the dynamics in the diagnosis and registration of patients with PID significantly intensified. For a period of 5 years (2016-2021) 101 patients were evaluated and registered in comparison with previous period - before ExpC establishment when only 89 patients were diagnosed. The most common pathology was humoral immune deficiency (85 patients; 44.5%). Ninety-six (50.3%) of the patients underwent genetic testing, and 66. 7% had genetically confirmed diagnosis. Three of the variants have not been reported in population databases. Following genetic investigation confirmation of the initial phenotypic diagnosis was achieved in 82.8% of cases and change in the diagnosis - in 17%. Sixty-two patients were on regular replacement or specific therapy, and the rest received symptomatic and supportive treatment. In summary, we present the first epidemiological report of PIDs in Bulgaria, based on the National PID register. Data on the clinical, phenotypic and genetic characteristics of PID patients provided important information about the nature of primary immunodeficiency diseases in our country.
format Online
Article
Text
id pubmed-9535737
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95357372022-10-07 Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center Naumova, Elissaveta Lesichkova, Spaska Milenova, Veneta Yankova, Petya Murdjeva, Marianna Mihailova, Snezhina Front Immunol Immunology Tremendous progress has been made in the recognition of primary immune deficiencies (PIDs) in Bulgaria since in 2005 we have joined the J Project Central-Eastern European collaborative program. Ten years later an Expert Centre (ExpC) for Rare Diseases - Primary Immune Deficiencies at the University Hospital “Alexandrovska”- Sofia was established. In May 2017 The National Register of Patients with Rare Diseases also became operational as a database containing clinical and genetic information for Bulgarian patients with PID. The transfer of data and information on Bulgarian PID patients to the European Primary Immunodeficiency Database, managed by the European Society for Primary Immunodeficiency (ESID) has started in 2020. The total number of registered patients now is 191 (100 men and 91 women), with more than half of them being children (106; 55.5%). Regular updating of the information in the register showed that 5.2% of patients are deceased and the majority (94.8%) is a subject to continuous monitoring as it has been reported for other European countries as well. With the establishment of the ExpC, the dynamics in the diagnosis and registration of patients with PID significantly intensified. For a period of 5 years (2016-2021) 101 patients were evaluated and registered in comparison with previous period - before ExpC establishment when only 89 patients were diagnosed. The most common pathology was humoral immune deficiency (85 patients; 44.5%). Ninety-six (50.3%) of the patients underwent genetic testing, and 66. 7% had genetically confirmed diagnosis. Three of the variants have not been reported in population databases. Following genetic investigation confirmation of the initial phenotypic diagnosis was achieved in 82.8% of cases and change in the diagnosis - in 17%. Sixty-two patients were on regular replacement or specific therapy, and the rest received symptomatic and supportive treatment. In summary, we present the first epidemiological report of PIDs in Bulgaria, based on the National PID register. Data on the clinical, phenotypic and genetic characteristics of PID patients provided important information about the nature of primary immunodeficiency diseases in our country. Frontiers Media S.A. 2022-09-22 /pmc/articles/PMC9535737/ /pubmed/36211402 http://dx.doi.org/10.3389/fimmu.2022.922752 Text en Copyright © 2022 Naumova, Lesichkova, Milenova, Yankova, Murdjeva and Mihailova https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Naumova, Elissaveta
Lesichkova, Spaska
Milenova, Veneta
Yankova, Petya
Murdjeva, Marianna
Mihailova, Snezhina
Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center
title Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center
title_full Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center
title_fullStr Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center
title_full_unstemmed Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center
title_short Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center
title_sort primary immunodeficiencies in bulgaria - achievements and challenges of the pid national expert center
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535737/
https://www.ncbi.nlm.nih.gov/pubmed/36211402
http://dx.doi.org/10.3389/fimmu.2022.922752
work_keys_str_mv AT naumovaelissaveta primaryimmunodeficienciesinbulgariaachievementsandchallengesofthepidnationalexpertcenter
AT lesichkovaspaska primaryimmunodeficienciesinbulgariaachievementsandchallengesofthepidnationalexpertcenter
AT milenovaveneta primaryimmunodeficienciesinbulgariaachievementsandchallengesofthepidnationalexpertcenter
AT yankovapetya primaryimmunodeficienciesinbulgariaachievementsandchallengesofthepidnationalexpertcenter
AT murdjevamarianna primaryimmunodeficienciesinbulgariaachievementsandchallengesofthepidnationalexpertcenter
AT mihailovasnezhina primaryimmunodeficienciesinbulgariaachievementsandchallengesofthepidnationalexpertcenter